Hemangiopericytoma: Difference between revisions

Jump to navigation Jump to search
Kalsang Dolma (talk | contribs)
No edit summary
Kalsang Dolma (talk | contribs)
Line 36: Line 36:
==Treatment==
==Treatment==
[[Hemangiopericytoma medical therapy|Medical Therapy]] | [[Hemangiopericytoma surgery|Surgery]] | [[Hemangiopericytoma primary prevention|Primary Prevention]] | [[Hemangiopericytoma secondary prevention|Secondary Prevention]] | [[Hemangiopericytoma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Hemangiopericytoma  future or investigational therapies|Future or Investigational Therapies]]
[[Hemangiopericytoma medical therapy|Medical Therapy]] | [[Hemangiopericytoma surgery|Surgery]] | [[Hemangiopericytoma primary prevention|Primary Prevention]] | [[Hemangiopericytoma secondary prevention|Secondary Prevention]] | [[Hemangiopericytoma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Hemangiopericytoma  future or investigational therapies|Future or Investigational Therapies]]
==Case Studies==
[[Hemangiopericytoma case study one|Case#1]]


==External Links==
==External Links==

Revision as of 19:44, 17 September 2012

For patient information, click here

Template:DiseaseDisorder infobox Template:Hemangiopericytoma Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Epidemiology and Demographics

Risk Factors

Screening

Differentiating Hemangiopericytoma from other Diseases

Natural History, Complications and Prognosis

Diagnosis

Staging | History and Symptoms | Physical Examination | Laboratory Findings | X Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case#1

External Links


Template:WikiDoc Sources